Skip to main content
. 2017 Apr 6;10(3):293–300. doi: 10.1093/ckj/sfx008

Cytokine–cytokine receptor interaction
BMP2, BMP4, BMP7, CCL2, CCL5, CCR5, EPO, GHR, IL10,  IL1B, IL1R1, IL4, IL6, IL6R, IL8, LTA, TGFB1, TGFBR1, TGFBR2, TNF, TNFRSF1A, TNFRSF1B, VEGA
Antigen processing and presentation
HLA-A, HLA-B, HLA-DQA1, HLA-DQB1, HLA-DRB1, HSPA1A, HSPA1B, HSPA1L, LTA
Natural killer cell-mediated cytotoxicity
BID, CASP3, HLA-A, HLA-B, ICAM1, NFAT5, PRKCB, TNF
T cell receptor signalling pathway
CTLA4, IL10, IL4, MALT1, NFAT5, NFKB1, TNF
B cell receptor signalling pathway
GSK3B, MALT1, NFAT5, NFKB1, PRKCB
Leucocyte transendothelial migration
GSK3B, MALT1, NFAT5, NFKB1, PRKCB
Other
GHRL, IL1RN, CCR2, ICAM4, CASP12, NOX4, NOX3, PRKCE, PRKCSH, MMP1, MMP3, MMP7, MMP8, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15, MMP16, MMP17, MMP19, MMP20, MMP24, MMP25, MMP26, MMP27, MMP28, TNFRSF9, TNFRSF19